Adenosine Deaminase-based Measurement in the Differential Diagnosis of Pleural Effusion: a Multicenter Retrospective Study

Overview

Journal Ther Adv Respir Dis

Publisher Sage Publications

Specialties Pharmacology
Pulmonary Medicine

Date 2023 Feb 27

PMID 36846945

Authors

Lijuan Gao

Wujun Wang

Ying Zhang

Xueru Hu

Jing An

Yang Li

Mei Chen

Yongchun Shen

Affiliations

Soon will be listed here.

Abstract

Introduction: The differential diagnosis of pleural effusion is difficult, and studies have reported on the potential role of adenosine deaminase (ADA) in the differential diagnosis of undiagnosed pleural effusion. This retrospective study aimed to investigate the diagnostic role of ADA in pleural effusion.

Methods: 266 patients with pleural effusion from three centers were enrolled. The concentrations of ADA and lactate dehydrogenase (LDH) were measured in pleural fluids and serum samples of the patients. The diagnostic performance of ADA-based measurement for tuberculous pleural effusion (TPE), malignant pleural effusion (MPE), and parapneumonic effusion (PPE) was examined by receiver operating characteristic (ROC) curve analysis.

Results: An area under the ROC curve (AUC) value of 0.909 was obtained using the pleural ADA values as the indicator for TPE identification (sensitivity: 87.50%, specificity: 87.82%). The ratio of serum LDH to pleural ADA (cancer ratio) provided the predictive capacity with an AUC of 0.879 for MPE diagnosis (sensitivity: 95.04%, specificity: 67.06%). At a cut-off value of 14.29, the pleural ADA/LDH ratio showed a sensitivity and specificity of 81.13% and 83.67%, respectively, and a high AUC value of 0.888 for the differential diagnosis of PPE from TPE.

Conclusion: ADA-based measurement is helpful for the differential diagnosis of pleural effusion. Further studies should be performed to validate these results.

Citing Articles

Diagnostic value of effusion adenosine deaminase, γ-interferon release assay and effusion lactatedehy drogenase/effusion adenosine deaminase for tuberculous pleural effusion in patients aged 60 years and above.

Guo F, Huimin C, Xia W, Xu Y, Jin W, Liu F Front Cell Infect Microbiol. 2024; 14:1444238.

PMID: 39445216 PMC: 11496274. DOI: 10.3389/fcimb.2024.1444238.

Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches.

Bartolomeu-Goncalves G, Souza J, Fernandes B, Spoladori L, Correia G, Castro I Diseases. 2024; 12(9).

PMID: 39329871 PMC: 11430992. DOI: 10.3390/diseases12090202.

ADA as main biochemical marker in patients with tuberculous effusion.

Jankovic J, Ilic B, durdevic N, Jandric A J Med Biochem. 2023; 42(4):722-726.

PMID: 38084235 PMC: 10710802. DOI: 10.5937/jomb0-44018.

Biomarkers for distinguishing tuberculous pleural effusion from non-tuberculosis effusion: a retrospective study.

Fei G, Yijun M, Weijiang J, Huimin C, Fang L BMC Infect Dis. 2023; 23(1):771.

PMID: 37940883 PMC: 10633909. DOI: 10.1186/s12879-023-08781-0.

Age affects the diagnostic accuracy of the cancer ratio for malignant pleural effusion.

Huang J, Chen H, Zhang Z, Gu J, Yan L, Jiang M BMC Pulm Med. 2023; 23(1):198.

PMID: 37286973 PMC: 10245516. DOI: 10.1186/s12890-023-02475-8.

References

Pfeiffer T, Schuster S, Bonhoeffer S . Cooperation and competition in the evolution of ATP-producing pathways. Science. 2001; 292(5516):504-7. DOI: 10.1126/science.1058079. View

Aggarwal A, Agarwal R, Sehgal I, Dhooria S . Adenosine deaminase for diagnosis of tuberculous pleural effusion: A systematic review and meta-analysis. PLoS One. 2019; 14(3):e0213728. PMC: 6435228. DOI: 10.1371/journal.pone.0213728. View

Nguyen A, Miller E, Wichman C, Berim I, Agrawal D . Diagnostic value of tumor antigens in malignant pleural effusion: a meta-analysis. Transl Res. 2015; 166(5):432-9. PMC: 4608857. DOI: 10.1016/j.trsl.2015.04.006. View

Choi B, Yoon M, Shin K, Lee Y, Song Y . Characteristics of pleural effusions in systemic lupus erythematosus: differential diagnosis of lupus pleuritis. Lupus. 2014; 24(3):321-6. DOI: 10.1177/0961203314555171. View

Lee J, Lim J, Yoo S, Lee S, Cha S, Park J . Radiologic and laboratory differences in patients with tuberculous and parapneumonic pleural effusions showing non-lymphocytic predominance and high adenosine deaminase levels. Infection. 2014; 43(1):65-71. DOI: 10.1007/s15010-014-0697-y. View

Greco S, Girardi E, Masciangelo R, Capoccetta G, Saltini C . Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis. 2003; 7(8):777-86. View

Yang Y, Liu Y, Shi H . Diagnostic Accuracy of Combinations of Tumor Markers for Malignant Pleural Effusion: An Updated Meta-Analysis. Respiration. 2017; 94(1):62-69. DOI: 10.1159/000468545. View

Botana-Rial M, Vazquez-Iglesias L, Casado-Rey P, Paez de la Cadena M, Andrade-Olivie M, Abal-Arca J . Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial. Sci Rep. 2020; 10(1):5679. PMC: 7105479. DOI: 10.1038/s41598-020-62388-y. View

Valdes L, San Jose E, Alvarez D, Valle J . Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Respir J. 1996; 9(4):747-51. DOI: 10.1183/09031936.96.09040747. View

10.

Porcel J, Esquerda A, Bielsa S . Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med. 2010; 21(5):419-23. DOI: 10.1016/j.ejim.2010.03.011. View

11.

Herrera Lara S, Fernandez-Fabrellas E, Samper G, Marco Buades J, Andreu Lapiedra R, Pinilla Moreno A . Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters. Lung. 2017; 195(5):653-660. DOI: 10.1007/s00408-017-0032-3. View

12.

van Keimpema A, Slaats E, WAGENAAR J . Adenosine deaminase activity, not diagnostic for tuberculous pleurisy. Eur J Respir Dis. 1987; 71(1):15-8. View

13.

Perez-Rodriguez E, Jimenez Castro D . The use of adenosine deaminase and adenosine deaminase isoenzymes in the diagnosis of tuberculous pleuritis. Curr Opin Pulm Med. 2000; 6(4):259-66. DOI: 10.1097/00063198-200007000-00002. View

14.

Zaric B, Kuruc V, Milovancev A, Markovic M, Sarcev T, Canak V . Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase?. Lung. 2008; 186(4):233-240. DOI: 10.1007/s00408-008-9085-7. View

15.

Verma A, Abisheganaden J, Light R . Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio). Lung. 2015; 194(1):147-53. PMC: 4740559. DOI: 10.1007/s00408-015-9831-6. View

16.

Clive A, Kahan B, Hooper C, Bhatnagar R, Morley A, Zahan-Evans N . Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax. 2014; 69(12):1098-104. PMC: 4251306. DOI: 10.1136/thoraxjnl-2014-205285. View

17.

Leeflang M, Moons K, Reitsma J, Zwinderman A . Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. Clin Chem. 2008; 54(4):729-37. DOI: 10.1373/clinchem.2007.096032. View

18.

Sanchez-Otero N, Blanco-Prieto S, Paez de la Cadena M, Vazquez-Iglesias L, Fernandez-Villar A, Botana-Rial M . Calprotectin: a novel biomarker for the diagnosis of pleural effusion. Br J Cancer. 2012; 107(11):1876-82. PMC: 3504943. DOI: 10.1038/bjc.2012.478. View

19.

Krenke R, Korczynski P . Use of pleural fluid levels of adenosine deaminase and interferon gamma in the diagnosis of tuberculous pleuritis. Curr Opin Pulm Med. 2010; 16(4):367-75. DOI: 10.1097/MCP.0b013e32833a7154. View

20.

Zhang Y, Li X, Liu J, Hu X, Wan C, Zhang R . Diagnostic accuracy of the cancer ratio for the prediction of malignant pleural effusion: evidence from a validation study and meta-analysis. Ann Med. 2021; 53(1):558-566. PMC: 8023604. DOI: 10.1080/07853890.2021.1906943. View